High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 3
SponsorChildren's Hospital of Fudan University
About this trial
This study is a prospective, single center and observational open clinical study.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Complicated with cirrhosis, hepatitis, or other hepatic disorders;
Complicated with other systemic serious diseases (such as congenital multiple malformations, chromosome abnormalities)
Trial population
The Kasai procedure for infants with biliary atresia under the age of 3 months.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
300 Participants
are grouped into 1 trial groupGroup A: high MCT formula nutritional support
Trial outcomes
Primary outcomes
1
Z-scores of body weight
The patient will be weighed in the recumbent position on an electronic infant scale. Z-scores for weight for age (WAZ) were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.
Time frame
3 months after Kasai portoenterostomySecondary outcomes
1
Z-scores of body length
Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.
Time frame
1 month after Kasai portoenterostomy2
Z-scores of body length
Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.
Time frame
3 months after Kasai portoenterostomy3
Z-scores of body length
Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.
Time frame
6 months after Kasai portoenterostomy4
Z-scores of body length
Z-scores were obtained from the World Health Organization Anthro software and WHO Child Growth Standards.
Time frame
1 year after Kasai portoenterostomySponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov